Hyperphosphorylation and cleavage at D421 enhance tau secretion.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMC 3352936)

Published in PLoS One on May 15, 2012

Authors

Vanessa Plouffe1, Nguyen-Vi Mohamed, Jessica Rivest-McGraw, Johanne Bertrand, Michel Lauzon, Nicole Leclerc

Author Affiliations

1: Département de pathologie et biologie cellulaire, Université de Montréal, Montréal, Québec, Canada.

Articles citing this

Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep (2013) 1.57

Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity. PLoS One (2013) 1.29

Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target. J Biol Chem (2014) 1.20

Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci (2014) 1.15

Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathol Commun (2014) 1.09

The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol (2013) 1.05

Formation and propagation of tau oligomeric seeds. Front Neurol (2013) 1.04

Cellular mechanisms of protein aggregate propagation. Curr Opin Neurol (2012) 1.01

Propagation of tau pathology in Alzheimer's disease: identification of novel therapeutic targets. Alzheimers Res Ther (2013) 1.00

Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem. Front Neurol (2013) 0.96

The role of extracellular Tau in the spreading of neurofibrillary pathology. Front Cell Neurosci (2014) 0.95

Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease. PLoS One (2013) 0.92

Ectosomes: a new mechanism for non-exosomal secretion of tau protein. PLoS One (2014) 0.92

Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease. J Neurochem (2015) 0.88

Prion-like propagation of protein aggregation and related therapeutic strategies. Neurotherapeutics (2013) 0.88

Prions and Protein Assemblies that Convey Biological Information in Health and Disease. Neuron (2016) 0.87

Starvation and inhibition of lysosomal function increased tau secretion by primary cortical neurons. Sci Rep (2014) 0.83

Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss. Sci Rep (2016) 0.81

Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies. Acta Neuropathol Commun (2016) 0.80

Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures. Cell Death Dis (2017) 0.75

The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells. Front Mol Neurosci (2017) 0.75

Therapeutic Strategies for Restoring Tau Homeostasis. Cold Spring Harb Perspect Med (2017) 0.75

Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease. Mol Neurodegener (2017) 0.75

Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies. Oncotarget (2017) 0.75

Articles cited by this

Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol (2009) 14.42

Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol (2006) 13.29

Neurodegenerative tauopathies. Annu Rev Neurosci (2001) 9.53

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology (1992) 9.30

Propagation of tau pathology in a model of early Alzheimer's disease. Neuron (2012) 6.23

CSF markers for incipient Alzheimer's disease. Lancet Neurol (2003) 6.12

Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature (1992) 5.27

Cells release prions in association with exosomes. Proc Natl Acad Sci U S A (2004) 5.17

Trans-synaptic spread of tau pathology in vivo. PLoS One (2012) 4.53

Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci (2005) 3.93

Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci (2005) 3.69

Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem (2011) 3.57

Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol (2009) 3.55

Caspase activation precedes and leads to tangles. Nature (2010) 3.24

Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol (2008) 3.17

The many faces of tau. Neuron (2011) 2.89

Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest (2004) 2.80

Temperature-sensitive steps in the transport of secretory proteins through the Golgi complex in exocrine pancreatic cells. Proc Natl Acad Sci U S A (1986) 2.58

The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem (1996) 2.41

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett (2000) 2.25

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Arch Gen Psychiatry (2004) 2.07

Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Arch Neurol (2005) 1.75

Total and phosphorylated tau protein as biological markers of Alzheimer's disease. Exp Gerontol (2009) 1.75

Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol (1995) 1.69

Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem (2007) 1.68

Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol Aging (2007) 1.65

Non-conventional trafficking of the cystic fibrosis transmembrane conductance regulator through the early secretory pathway. J Biol Chem (2002) 1.50

Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci Lett (2007) 1.41

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol (2002) 1.41

SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain. FASEB J (2005) 1.41

Interneuronal transfer of human tau between Lamprey central neurons in situ. J Alzheimers Dis (2010) 1.39

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett (2000) 1.31

The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J Neurochem (1997) 1.26

Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (1987) 1.22

Tau transgenic mice as models for cerebrospinal fluid tau biomarkers. J Alzheimers Dis (2011) 1.19

Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles. FEBS Lett (2011) 1.17

Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau. J Biol Chem (2010) 1.15

Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments. Dementia (1997) 1.15

Secretion of human tau fragments resembling CSF-tau in Alzheimer's disease is modulated by the presence of the exon 2 insert. FEBS Lett (2010) 1.10

Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease. Neurosci Lett (1999) 1.08

Increased membrane cholesterol might render mature hippocampal neurons more susceptible to beta-amyloid-induced calpain activation and tau toxicity. J Neurosci (2009) 1.02

Improperly folded green fluorescent protein is secreted via a non-classical pathway. J Cell Sci (2002) 1.01

Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231. Ann Neurol (2001) 0.95

Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231. Am J Psychiatry (2003) 0.95

Total and phosphorylated tau proteins: evaluation as core biomarker candidates in frontotemporal dementia. Dement Geriatr Cogn Disord (2004) 0.93

The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons. Neuroscience (2010) 0.92

Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles. Neurobiol Aging (2003) 0.91

Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology. Acta Neuropathol (2002) 0.89

Increased association between rough endoplasmic reticulum membranes and mitochondria in transgenic mice that express P301L tau. J Neuropathol Exp Neurol (2009) 0.88

Microtubule-associated proteins, phosphorylation gradients, and the establishment of neuronal polarity. Perspect Dev Neurobiol (1996) 0.85

Protein secretion and the Golgi apparatus. Mol Membr Biol (2003) 0.77

Articles by these authors

Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neurite outgrowth on inhibitory substrates. J Biol Chem (2002) 1.09

Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission. Eur J Neurosci (2013) 1.05

Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. J Biol Chem (2012) 1.04

Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons. Am J Pathol (2005) 0.96

Tau interacts with Golgi membranes and mediates their association with microtubules. Cell Motil Cytoskeleton (2006) 0.95

Interaction of microtubule-associated protein-2 and p63: a new link between microtubules and rough endoplasmic reticulum membranes in neurons. J Biol Chem (2004) 0.91

Increased association between rough endoplasmic reticulum membranes and mitochondria in transgenic mice that express P301L tau. J Neuropathol Exp Neurol (2009) 0.88

HMWMAP2: new perspectives on a pathway to dendritic identity. Cell Motil Cytoskeleton (2008) 0.83

Taking organelles apart, putting them back together and creating new ones: lessons from the endoplasmic reticulum. Prog Histochem Cytochem (2011) 0.82

The formation of tau pathological phospho-epitopes in the axon is prevented by the dephosphorylation of selective sites in primary hippocampal neurons over-expressing human tau. J Neurochem (2010) 0.81

Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles. Biochemistry (2013) 0.81

The projection domain of MAP2b regulates microtubule protrusion and process formation in Sf9 cells. J Cell Sci (2002) 0.79

Vaccination stimulates retinal ganglion cell regeneration in the adult optic nerve. Neurobiol Dis (2003) 0.76